The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.
Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition
Open accessAbstract
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly contagious respiratory virus that can lead to venous/arterial thrombosis, stroke, renal failure, myocardial infarction, thrombocytopenia, and other end-organ damage. Animal models demonstrating end-organ protection in C3-deficient mice and evidence of complement activation in humans have led to the hypothesis that SARS-CoV-2 triggers complement-mediated endothelial damage, but the mechanism is unclear. Here, we demonstrate that the SARS-CoV-2 spike protein (subunit 1 and 2), but not the N protein, directly activates the alternative pathway of complement (APC). Complement-dependent killing using the modified Ham test is blocked by either C5 or factor D inhibition. C3 fragments and C5b-9 are deposited on TF1PIGAnull target cells, and complement factor Bb is increased in the supernatant from spike protein–treated cells. C5 inhibition prevents the accumulation of C5b-9 on cells, but not C3c; however, factor D inhibition prevents both C3c and C5b-9 accumulation. Addition of factor H mitigates the complement attack. In conclusion, SARS-CoV-2 spike proteins convert nonactivator surfaces to activator surfaces by preventing the inactivation of the cell-surface APC convertase. APC activation may explain many of the clinical manifestations (microangiopathy, thrombocytopenia, renal injury, and thrombophilia) of COVID-19 that are also observed in other complement-driven diseases such as atypical hemolytic uremic syndrome and catastrophic antiphospholipid antibody syndrome. C5 inhibition prevents accumulation of C5b-9 in vitro but does not prevent upstream complement activation in response to SARS-CoV-2 spike proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., Qiu, Y., Wang, J., Liu, Y., Wei, Y., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30211-7 · Cited by 21,415
Richardson, S., Hirsch, J. S., Narasimhan, M., Crawford, J. M., McGinn, T., Davidson, K. W., and the Northwell COVID-19 Research Consortium, Barnaby, D. P., Becker, L. B., Chelico, J. D., et al. (2020) · JAMA · doi:10.1001/jama.2020.6775 · Cited by 9,254
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
Lan, J., Ge, J., Yu, J., Shan, S., Zhou, H., Fan, S., Zhang, Q., Shi, X., Wang, Q., Zhang, L., et al. (2020) · Nature · doi:10.1038/s41586-020-2180-5 · Cited by 5,983
Self-citationTang, N., Li, D., Wang, X., & Sun, Z. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14768 · Cited by 5,662
The proximal origin of SARS-CoV-2
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0820-9 · Cited by 5,081
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. (2015) · Methods in Molecular Biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,787
CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis), Helms, J., Tacquard, C., Severac, F., Leonard-Lorant, I., Ohana, M., Delabranche, X., Merdji, H., Clere-Jehl, R., Schenck, M., et al. (2020) · Intensive Care Medicine · doi:10.1007/s00134-020-06062-x · Cited by 2,792
Magro, C., Mulvey, J. J., Berlin, D., Nuovo, G., Salvatore, S., Harp, J., Baxter-Stoltzfus, A., & Laurence, J. (2020) · Translational Research · doi:10.1016/j.trsl.2020.04.007 · Cited by 2,183
Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19
Zhang, Y., Xiao, M., Zhang, S., Xia, P., Cao, W., Jiang, W., Chen, H., Ding, X., Zhao, H., Zhang, H., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmc2007575 · Cited by 2,179
Self-citationCoronaviruses post-SARS: update on replication and pathogenesis
Perlman, S., & Netland, J. (2009) · Nature Reviews Microbiology · doi:10.1038/nrmicro2147 · Cited by 1,764
Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues
Li, M.-Y., Li, L., Zhang, Y., & Wang, X.-S. (2020) · Infectious Diseases of Poverty · doi:10.1186/s40249-020-00662-x · Cited by 1,583
Acute kidney injury in patients hospitalized with COVID-19
Hirsch, J. S., Ng, J. H., Ross, D. W., Sharma, P., Shah, H. H., Barnett, R. L., Hazzan, A. D., Fishbane, S., Jhaveri, K. D., Abate, M., et al. (2020) · Kidney International · doi:10.1016/j.kint.2020.05.006 · Cited by 1,523
Proteomic and Metabolomic Characterization of COVID-19 Patient Sera
Shen, B., Yi, X., Sun, Y., Bi, X., Du, J., Zhang, C., Quan, S., Zhang, F., Sun, R., Qian, L., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.032 · Cited by 1,514
Self-citationThe pivotal link between ACE2 deficiency and SARS-CoV-2 infection
Verdecchia, P., Cavallini, C., Spanevello, A., & Angeli, F. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.04.037 · Cited by 1,237
Spiezia, L., Boscolo, A., Poletto, F., Cerruti, L., Tiberio, I., Campello, E., Navalesi, P., & Simioni, P. (2020) · Thrombosis and Haemostasis · doi:10.1055/s-0040-1710018 · Cited by 699
Complement Activation Contributes to Severe Acute Respiratory Syndrome Coronavirus Pathogenesis
Gralinski, L. E., Sheahan, T. P., Morrison, T. E., Menachery, V. D., Jensen, K., Leist, S. R., Whitmore, A., Heise, M. T., & Baric, R. S. (2018) · mBio · doi:10.1128/mbio.01753-18 · Cited by 655
Complement and coagulation: strangers or partners in crime?
Markiewski, M. M., Nilsson, B., Nilsson Ekdahl, K., Mollnes, T. E., & Lambris, J. D. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.02.006 · Cited by 645
History and Recent Advances in Coronavirus Discovery
Kahn, J. S., & McIntosh, K. (2005) · Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000188166.17324.60 · Cited by 619
Hillmen, P., Muus, P., Dührsen, U., Risitano, A. M., Schubert, J., Luzzatto, L., Schrezenmeier, H., Szer, J., Brodsky, R. A., Hill, A., et al. (2007) · Blood · doi:10.1182/blood-2007-06-095646 · Cited by 579
Self-citationAge-Related Macular Degeneration: Genetics and Biology Coming Together
Fritsche, L. G., Fariss, R. N., Stambolian, D., Abecasis, G. R., Curcio, C. A., & Swaroop, A. (2014) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-090413-025610 · Cited by 534
Complement as a target in COVID-19?
Risitano, A. M., Mastellos, D. C., Huber-Lang, M., Yancopoulou, D., Garlanda, C., Ciceri, F., & Lambris, J. D. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0320-7 · Cited by 484
Gao, T., Zhu, L., Liu, H., Zhang, X., Wang, T., Fu, Y., Li, H., Dong, Q., Hu, Y., Zhang, Z., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01133-5 · Cited by 436
Elharrar, X., Trigui, Y., Dols, A.-M., Touchon, F., Martinez, S., Prud’homme, E., & Papazian, L. (2020) · JAMA · doi:10.1001/jama.2020.8255 · Cited by 411
The complement system in COVID-19: friend and foe?
Java, A., Apicelli, A. J., Liszewski, M. K., Coler-Reilly, A., Atkinson, J. P., Kim, A. H. J., & Kulkarni, H. S. (2020) · JCI Insight · doi:10.1172/jci.insight.140711 · Cited by 376
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection
Ramlall, V., Thangaraj, P. M., Meydan, C., Foox, J., Butler, D., Kim, J., May, B., De Freitas, J. K., Glicksberg, B. S., Mason, C. E., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1021-2 · Cited by 351
A rare penetrant mutation in CFH confers high risk of age-related macular degeneration
Raychaudhuri, S., Iartchouk, O., Chin, K., Tan, P. L., Tai, A. K., Ripke, S., Gowrisankar, S., Vemuri, S., Montgomery, K., Yu, Y., et al. (2011) · Nature Genetics · doi:10.1038/ng.976 · Cited by 323
Kim, S. Y., Jin, W., Sood, A., Montgomery, D. W., Grant, O. C., Fuster, M. M., Fu, L., Dordick, J. S., Woods, R. J., Zhang, F., et al. (2020) · Antiviral Research · doi:10.1016/j.antiviral.2020.104873 · Cited by 311
Structures of C3b in Complex with Factors B and D Give Insight into Complement Convertase Formation
Forneris, F., Ricklin, D., Wu, J., Tzekou, A., Wallace, R. S., Lambris, J. D., & Gros, P. (2010) · Science · doi:10.1126/science.1195821 · Cited by 288
Will Complement Inhibition Be the New Target in Treating COVID-19–Related Systemic Thrombosis?
Campbell, C. M., & Kahwash, R. (2020) · Circulation · doi:10.1161/circulationaha.120.047419 · Cited by 267
Complement activation in patients with COVID-19: A novel therapeutic target
Cugno, M., Meroni, P. L., Gualtierotti, R., Griffini, S., Grovetti, E., Torri, A., Panigada, M., Aliberti, S., Blasi, F., Tedesco, F., et al. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.05.006 · Cited by 247
Heparan Sulfate Proteoglycans as Attachment Factor for SARS-CoV-2
Liu, L., Chopra, P., Li, X., Bouwman, K. M., Tompkins, S. M., Wolfert, M. A., de Vries, R. P., & Boons, G.-J. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00010 · Cited by 232
Chaturvedi, S., Braunstein, E. M., Yuan, X., Yu, J., Alexander, A., Chen, H., Gavriilaki, E., Alluri, R., Streiff, M. B., Petri, M., et al. (2020) · Blood · doi:10.1182/blood.2019003863 · Cited by 231
Self-citationRisitano, A. M., Marotta, S., Ricci, P., Marano, L., Frieri, C., Cacace, F., Sica, M., Kulasekararaj, A., Calado, R. T., Scheinberg, P., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01157 · Cited by 224
Orth, D., Khan, A. B., Naim, A., Grif, K., Brockmeyer, J., Karch, H., Joannidis, M., Clark, S. J., Day, A. J., Fidanzi, S., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900151 · Cited by 209
Jiang, Y., Zhao, G., Song, N., Li, P., Chen, Y., Guo, Y., Li, J., Du, L., Jiang, S., Guo, R., et al. (2018) · Emerging Microbes & Infections · doi:10.1038/s41426-018-0063-8 · Cited by 195
Binding of Avian Coronavirus Spike Proteins to Host Factors Reflects Virus Tropism and Pathogenicity
Wickramasinghe, I. N. A., de Vries, R. P., Gröne, A., de Haan, C. A. M., & Verheije, M. H. (2011) · Journal of Virology · doi:10.1128/jvi.05112-11 · Cited by 181
Severe COVID‐19 infection and thrombotic microangiopathy: success does not come easily
Gavriilaki, E., & Brodsky, R. A. (2020) · British Journal of Haematology · doi:10.1111/bjh.16783 · Cited by 178
Self-citationAcute Stroke in Times of the COVID-19 Pandemic: A Multicenter Study
Hoyer, C., Ebert, A., Huttner, H. B., Puetz, V., Kallmünzer, B., Barlinn, K., Haverkamp, C., Harloff, A., Brich, J., Platten, M., et al. (2020) · Stroke · doi:10.1161/strokeaha.120.030395 · Cited by 176
Sialic acids as receptor determinants for coronaviruses
Schwegmann-Weßels, C., & Herrler, G. (2006) · Glycoconjugate Journal · doi:10.1007/s10719-006-5437-9 · Cited by 175
Harder, M. J., Kuhn, N., Schrezenmeier, H., Höchsmann, B., von Zabern, I., Weinstock, C., Simmet, T., Ricklin, D., Lambris, J. D., Skerra, A., et al. (2016) · Blood · doi:10.1182/blood-2016-08-732800 · Cited by 168
Genetics of Atypical Hemolytic Uremic Syndrome (aHUS)
Hidalgo, M., Pinto, S., Tortajada, A., & de Córdoba, S. R. (2014) · Seminars in Thrombosis and Hemostasis · doi:10.1055/s-0034-1375296 · Cited by 149
Thrombotic microangiopathy in a patient with COVID-19
Jhaveri, K. D., Meir, L. R., Chang, B. S. F., Parikh, R., Wanchoo, R., Barilla-LaBarca, M.-L., Bijol, V., & Hajizadeh, N. (2020) · Kidney International · doi:10.1016/j.kint.2020.05.025 · Cited by 144
Marchetti, M. (2020) · Annals of Hematology · doi:10.1007/s00277-020-04138-8 · Cited by 139
Baines, A. C., & Brodsky, R. A. (2017) · Blood Reviews · doi:10.1016/j.blre.2017.02.003 · Cited by 120
Self-citationJokiranta, T. S., Cheng, Z. ‐., Seeberger, H., Józsi, M., Heinen, S., Noris, M., Remuzzi, G., Ormsby, R. J., Gordon, D., Meri, S., et al. (2005) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61205-9 · Cited by 118
Binding of the SARS-CoV-2 spike protein to glycans
Hao, W., Ma, B., Li, Z., Wang, X., Gao, X., Li, Y., Qin, B., Shang, S., Cui, S., & Tan, Z. (2021) · 中国科学通报:英文版 · doi:10.1016/j.scib.2021.01.010 · Cited by 117
Complementopathies and precision medicine
Gavriilaki, E., & Brodsky, R. A. (2020) · Journal of Clinical Investigation · doi:10.1172/jci136094 · Cited by 115
Self-citationVaught, A. “. J., Gavriilaki, E., Hueppchen, N. A., Blakemore, K. J., Yuan, X., Seifert, S. M., York, S., & Brodsky, R. A. (2016) · Experimental Hematology · doi:10.1016/j.exphem.2016.01.005 · Cited by 114
Self-citationModified Ham test for atypical hemolytic uremic syndrome
Gavriilaki, E., Yuan, X., Ye, Z., Ambinder, A. J., Shanbhag, S., Streiff, M. B., Kickler, T. S., Moliterno, A. R., Sperati, C. J., & Brodsky, R. A. (2015) · Blood · doi:10.1182/blood-2015-02-629683 · Cited by 113
Self-citationYuan, X., Gavriilaki, E., Thanassi, J. A., Yang, G., Baines, A. C., Podos, S. D., Huang, Y., Huang, M., & Brodsky, R. A. (2016) · Haematologica · doi:10.3324/haematol.2016.153312 · Cited by 112
Self-citationComplement-coagulation connections
Conway, E. M. (2018) · Blood Coagulation & Fibrinolysis · doi:10.1097/mbc.0000000000000720 · Cited by 100
Germline mutations in the alternative pathway of complement predispose to HELLP syndrome
Vaught, A. “. J., Braunstein, E. M., Jasem, J. A., Yuan, X., Makhlin, I., Eloundou, S. N., Baines, A. C., Merrill, S. A., Chaturvedi, S., Blakemore, K. J., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99128 · Cited by 97
Self-citationde Chambrun, M. P., Frère, C., Miyara, M., Amoura, Z., Martin‐Toutain, I., Mathian, A., Hékimian, G., & Combes, A. (2020) · Journal of Internal Medicine · doi:10.1111/joim.13126 · Cited by 91
Complementing the sugar code: Role of GAGs and sialic acid in complement regulation
Langford-Smith, A., Day, A. J., Bishop, P. N., & Clark, S. J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00025 · Cited by 80 · cited 1×
“35,42,43 Factor H is made up of 20 complement control protein (CCP) modules (also referred to as sushi domains or short consensus repeats).”
BackgroundHuman Rhinovirus Type 89 Variants Use Heparan Sulfate Proteoglycan for Cell Attachment
Vlasak, M., Goesler, I., & Blaas, D. (2005) · Journal of Virology · doi:10.1128/jvi.79.10.5963-5970.2005 · Cited by 77
Hyvärinen, S., Meri, S., & Jokiranta, T. S. (2016) · Blood · doi:10.1182/blood-2015-11-680009 · Cited by 75
Molecular Interactions between Complement Factor H and Its Heparin and Heparan Sulfate Ligands
Perkins, S. J., Fung, K. W., & Khan, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00126 · Cited by 74
Herbert, A. P., Makou, E., Chen, Z. A., Kerr, H., Richards, A., Rappsilber, J., & Barlow, P. N. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1501388 · Cited by 73
Langdown, J., Belzar, K. J., Savory, W. J., et al. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.01.028 · Cited by 57
Heparan sulfate-protein binding specificity
Nugent, M. A., Zaia, J., & Spencer, J. L. (2013) · Biochemistry (Moscow) · doi:10.1134/s0006297913070055 · Cited by 40
Vaught, A. “. J., Braunstein, E. M., Chaturvedi, S., Blakemore, K. J., & Brodsky, R. A. (2020) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2020.1755650 · Cited by 17
Self-citationOsborne, A. J., Nan, R., Miller, A., Bhatt, J. S., Gor, J., & Perkins, S. J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004767 · Cited by 14
Cited by
Understanding COVID-19-associated coagulopathy
Conway, E. M., Mackman, N., Warren, R. Q., Wolberg, A. S., Mosnier, L. O., Campbell, R. A., Gralinski, L. E., Rondina, M. T., van de Veerdonk, F. L., Hoffmeister, K. M., et al. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00762-9 · Cited by 359
A guide to complement biology, pathology and therapeutic opportunity
Mastellos, D. C., Hajishengallis, G., & Lambris, J. D. (2024) · Nature Reviews Immunology · doi:10.1038/s41577-023-00926-1 · Cited by 320
The state of complement in COVID-19
Afzali, B., Noris, M., Lambrecht, B. N., & Kemper, C. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-021-00665-1 · Cited by 293
Crosstalk between the renin–angiotensin, complement and kallikrein–kinin systems in inflammation
Bekassy, Z., Lopatko Fagerström, I., Bader, M., & Karpman, D. (2022) · Nature reviews. Immunology · doi:10.1038/s41577-021-00634-8 · Cited by 167
Montano, D. (2022) · Frontiers in Public Health · doi:10.3389/fpubh.2021.756633 · Cited by 70
Metadata
- Authors
- Yu, J., Yuan, X., Chen, H., Chaturvedi, S., Braunstein, E. M., & Brodsky, R. A.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2020-10-29
- Volume
- 136
- Issue
- 18
- Pages
- 2080-2089
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W3082365904
- Cited by
- 374
- References
- 62
- FWCI
- 21.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.